300080.SZ
300080.SZ
CNE100000QK0
YCXN
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 37/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.6x).

Beta (Market Relation)
0.64x
Defensive
Volatility (5Y p.a.)
49.1% p.a.
5-Year Horizon
Max Drawdown (5Y)
-61.7%
5-Year Horizon
Sharpe Ratio
-0.25
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -31.8%
3 Years 54.9% -50.1% -0.21 -8.8%
5 Years 49.1% -61.7% -0.25 -10.6%
10 Years 49.7% -75.1% -0.19 -7%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Elevated Short-Term Volatility: 3Y volatility (54.9%) is noticeably higher than the 5Y average (49.1%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (49.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -75.1% in the extended horizon.
ende